Comments Off on Lung Cancer Drug, Osimertinib, Drastically Reduces Death Risk after Surgery
Lung cancer is among most common types of cancers in U.S. as well as around the world. According to the Centers for Disease Control and Prevention, it is [...]
This is a fact accepted worldwide with evidences that lung cancer is old age disease. Lung cancer patients more then 50% are diagnosed after the age of 65, [...]
Comments Off on Lung Cancer Outcomes May Be Improved By Chemo With TKI Drug
Gefitinib and chemotherapy may be considered a first-line treatment option for patients with EGFR-mutated Non-Small Cell Lung Cancer (NSCLC) with brain [...]
Comments Off on MIT Researchers Find Why Immunotherapy Doesn’t Respond To Lung Cancer Treatment
World Cancer Day is observed on February 4 every year. This day is dedicated to spreading awareness about various types of cancers and mainly focusing on early [...]
Comments Off on FDA Approves Adjuvant Pembrolizumab for Non-Small Cell Lung Cancer Treatment
The US Food and Drug Administration has approved Pembrolizumab for adjuvant treatment following resection and platinum-based chemotherapy in patients with [...]
Comments Off on Columbia Biomedical Engineers Develop New Bacterial Therapy for Lung Cancer Treatment
Lung cancer is one of the most deadly types of cancers in the United States as well as around the world. As most of the therapies have been ineffective, this [...]
Comments Off on Study Shows Alarming Rise in Lung Cancer Cases among non-smokers, Youth and Women
A study has been conducted by team of doctors from Medanta Gurugram, India that suggests possible increase in non-smokers and women lung cancer cases. Dr. [...]
Comments Off on Lung Cancer Awareness Month Theme is “A Breath of Prevention”
Lung cancer is one of the most deadly diseases that affects both men and women all around the world. It is the second common type of cancer. It is responsible [...]
Comments Off on US FDA Approves Imfinzi and Imjudo with Chemotherapy for Lung Cancer
AstraZeneca’s Imfinzi in combination with Imjudo plus platinum-based chemotherapy has been approved for treatment of patients with Stage IV non-small cell [...]
Comments Off on Experimental Drug Treatment Stops Lung Cancer in Mice
Small cell lung cancer is one of the deadly diseases and now scientists may have promising new avenue as they have been able to effectively stop the growth of [...]
Comments Off on FDA Grants Approval to Trastuzumab Deruxtecan for HER2 Lung Cancer
Lung cancer patients now have another treatment option. For those tumors carrying HER2 mutations, can now be treated with trastuzumab deruxtecan. This drug is [...]
Comments Off on Lung Cancer Treatment Side Effects Prevented with Genetic Discovery
Lung cancer is one of the deadliest forms of cancers prevalent globally. Immunotherapy has emerged as one of the most effective ways to control this disease. [...]